-+ 0.00%
-+ 0.00%
-+ 0.00%

Femasys Partners With Medical Electronic Systems To Provide Advanced Sperm Analysis Technology

Benzinga·09/22/2025 13:02:19
Listen to the news

Femasys Inc. (NASDAQ:FEMY), a leading biomedical innovator making fertility and non-surgical permanent birth control more accessible and cost-effective to women worldwide, announced today a partnership with Medical Electronic Systems LLC (MES) to provide advanced sperm analysis technology. The FemSperm Analysis Kit completes the FemSperm product family, joining the Setup Kit and Insemination Prep Kit. Together, they expand Femasys' infertility portfolio and, for the first time, enables gynecologists to perform in-office sperm preparation and analysis for use with its first-step infertility treatment, FemaSeed Intratubal Insemination.